Self-paced • 0.5 credits
About this course
Genomic tumor testing includes a range of test options with varying benefits and limitations. Increasingly, “genomic” tests that assess DNA variants include multiple test methods which can assess other types of biomarkers, such as RNA and protein expression that also can help to inform appropriateness of targeted treatments and immunotherapy. This course will help you differentiate among these test options by working through cases and learning more about (1) tests used to detect DNA variants, (2) tests used to detect immunotherapy biomarkers and (3) the origin of cells and genetic material used in the analysis. This module uses practice cases to facilitate learning-by-doing, discussion of in-depth topics, and additional resources for more detail.
Upon completion of this educational activity, the learner will be able to:
- Identify and manage individuals with cancer for whom genomic tumor testing is indicated.
Oncologists and other cancer clinicians, including fellows, physician assistants and nurses
All information in Precision Oncology Online Education is provided for educational purposes only. This information is not a substitute for clinical guidance or the consultation of a medical professional. Always seek the advice of a qualified health professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in Precision Oncology Online Education. Reliance on any information in Precision Oncology Online Education is solely at your own risk. The Jackson Laboratory does not endorse or recommend any specific procedures, tests, products, services, health professionals or other information that may be found in Precision Oncology Online Education.